LIFT HIV Summit

This session equips participants with the skills to critically evaluate grant proposals and understand the key factors that influence funding decisions. Participants will explore why proposals succeed or fail, examining elements such as alignment with funder priorities, clarity of need, strength of evidence, feasibility of implementation, and measurable outcomes.

This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

• Media: Enduring Material
• Release Date: 03/23/26
• Expiration Date: 03/23/27
• Time to Complete: 60 Minutes

Upon completion of this activity, participants will be better able to:

• Explain why grant proposals might succeed or fail
• Identify gaps in grant readiness
• Describe actionable steps to improve grant funding competitiveness

Participants can earn up to 1.0 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of the certification program.

In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits.

Approval is valid until 03/23/2027. PAs should only claim credit commensurate with the extent of their participation.

Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

HealthHIV designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

UAN: JA4008396-0000-26-016-H99-P

As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program.  Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.

This program has no commercial support.

The planners and content/peer reviewers from HealthHIV do not have any relevant financial relationships to disclose with ineligible companies.

Melissa A. Kelley, EdD, CHES®
Director of Training
HealthHIV
Washington, DC

Disclosure: Melissa Kelley has no relevant financial relationships to disclose with ineligible companies.

HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit.  Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV. 

Artificial Intelligence (AI) holds significant promise for advancing public health impact, specifically in HIV prevention and care by enabling more timely, personalized, and data-driven interventions like predicting outbreaks and identifying high-risk populations through geospatial mapping, powering chatbots that offer stigma-free education and support, and optimizing treatment plans to improve adherence and outcomes, However, these opportunities also introduce complex ethical, technical, and operational challenges. This breakout session will examine how AI can be responsibly designed and deployed in HIV-focused public health settings, with attention to data quality, system integration, bias mitigation, privacy protection, and the risks of inaccurate or misleading outputs. Participants will leave with a grounded understanding of how to balance innovation with accountability in the ethical use of AI in public health.

This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

• Media: Enduring Material
• Release Date: 03/23/26
• Expiration Date: 03/23/27
• Time to Complete: 60 Minutes

Upon completion of this activity, participants will be better able to:

• Describe key applications of AI in HIV prevention and care, including outbreak prediction, geospatial risk mapping, AI-driven education tools, and treatment optimization
• Identify ethical and operational challenges associated with AI implementation, such as data quality limitations, privacy risks, and AI hallucinations.
• Apply principles for developing and selecting ethical AI solutions, including transparency, bias reduction, and alignment with clinical and public health workflows
• Recognize the importance of community engagement and equity-centered design, and outline strategies for involving diverse populations to ensure AI tools are culturally appropriate, trusted, and equitable

Participants can earn up to 1.0 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of the certification program.

In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits.

Approval is valid until 03/23/2027. PAs should only claim credit commensurate with the extent of their participation.

Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

HealthHIV designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

UAN: JA4008396-0000-26-023-H02-P

As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program.  Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.

This program has no commercial support.

The planners and content/peer reviewers from HealthHIV do not have any relevant financial relationships to disclose with ineligible companies.

Greg Scott Irwin, PMP
Senior Managing Consultant, Tefria

Disclosure: Greg Scott Irwin has disclosed the following relevant financial relationships with an ineligible company: 

• Ownership interest other than stock options, stocks or bonds in ConcernCenter 
• Is an employee of Tegria

HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit.  Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV. 

Climate-related emergencies, infrastructure failures, and public health crises are increasingly disrupting HIV prevention and care services across diverse areas. This breakout session will equip HIV service organizations with practical strategies to maintain continuity of care before, during, and after disasters. Participants will explore best practices, approaches to ensuring medication access during emergencies, and the use of alternate care models when clinics or transportation systems are compromised. The session will also examine how disasters intensify homelessness and HIV vulnerability, and how organizations can respond with client-centered, community-driven solutions.

This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers.

• Media: Enduring Material
• Release Date: 03/23/26
• Expiration Date: 03/23/27
• Time to Complete: 60 Minutes

Upon completion of this activity, participants will be better able to:

• Identify key risks climate emergencies and infrastructure disruptions pose to HIV prevention and care delivery in the DC/Maryland/Virginia region, particularly for people experiencing homelessness.
• Describe disaster-resilient service models, including strategies for maintaining medication access (ART, PrEP, PEP) and delivering alternative care when traditional systems fail.
• Recognize emergency preparedness and response strategies to strengthen organizational readiness, cross-sector coordination, and continuity of HIV services during and after disasters.

Participants can earn up to 1.0 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of the certification program.

In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits.

Approval is valid until 03/23/2027. PAs should only claim credit commensurate with the extent of their participation.

Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

HealthHIV designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

UAN: JA4008396-0000-26-018-H02-P

As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program.  Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

The planners and content/peer reviewers from HealthHIV do not have any relevant financial relationships to disclose with ineligible companies.

Julie Karr, MPH
Senior Program Analyst, STI HIV Syndemics
National Association of County & City Health Officials
Washington, DC

Disclosure: Julie Karr, MPH has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Jerry Joseph, MPH
Director of Preparedness
National Association of County & City Health Officials
Washington, DC

Disclosure: Jerry Joseph, MPH has no relevant financial relationships with ineligible companies to disclose for this educational activity.

HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit.  Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV. 

Psychedelic Assisted Therapy (PAT) is a form of psychotherapy that involves the combining of psychedelic substances such as psilocybin, MDMA, and ketamine with psychotherapy. This session introduces the legal, regulatory, and ethical landscape surrounding psychedelic substances in clinical and community contexts. Participants will review core components of psychedelic-assisted therapy and harm-reduction models, with attention to scope of practice and risk management. The session will also cover key screening principles to help clinicians identify appropriate and inappropriate candidates for psychedelic-related work.

This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

• Media: Enduring Material
• Release Date: 03/23/26
• Expiration Date: 03/23/27
• Time to Complete: 60 Minutes

Upon completion of this activity, participants will be better able to:

• Recognize the current legal status, regulatory considerations, and ethical risks related to psychedelic substances
• Explore core components of psychedelic-assisted therapy and psychedelic harm-reduction models
• Describe clinical screening principles to identify appropriate and inappropriate candidates for psychedelic-related work.

Participants can earn up to 1.0 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of the certification program.

In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 03/23/2027. PAs should only claim credit commensurate with the extent of their participation.

Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

HealthHIV designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

UAN: JA4008396-0000-26-019-H02-P

As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program.  Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.

The planners and content/peer reviewers from HealthHIV do not have any relevant financial relationships to disclose with ineligible companies.

Lauren Going, LCSW-C RYT
Inner Path Wellness
Baltimore, MD

Disclosure: Lauren Going has no relevant financial relationships with ineligible companies to disclose for this educational activity.

HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit.  Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.